Global Advanced Drug Delivery Systems Market Growth (Status and Outlook) 2023-2029
Advanced drug delivery systems are the improved methods for delivering the drug molecule to the targeted site in a more controlled manner. These methods are developed in order to improve the efficacy ratio of the currently available drugs. Delivering drug at the controlled rate, slow and targeted delivery for onsite drug release and absorption are the basis for the development of advanced drug delivery systems. Furthermore, the development of improved methods of drug delivery is preferred these days over the search for novel molecules. There are various dosage forms available by which a drug substance can be incorporated for efficacious delivery. Advancements in biotechnology and nanotechnology have significantly boosted the development of novel drug delivery approaches. Various interdisciplinary studies in the field of polymer science, pharmaceuticals, organic chemistry and molecular biology are required for the development of advanced drug delivery systems. The drug delivery system comprise of drug formulation, dosage form and mechanism of release. These advanced delivery systems have the potential of overcoming one of the major problem faced by the pharmaceutical industry for the onsite drug efficacy. Development of advanced drug delivery systems needs into consideration several factors such as pharmacodynamics, drug toxicity, immunogenicity, bio compatibility, pharmacokinetics as well as drug efficacy.
LPI (LP Information)' newest research report, the “Advanced Drug Delivery Systems Industry Forecast” looks at past sales and reviews total world Advanced Drug Delivery Systems sales in 2022, providing a comprehensive analysis by region and market sector of projected Advanced Drug Delivery Systems sales for 2023 through 2029. With Advanced Drug Delivery Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Advanced Drug Delivery Systems industry.
This Insight Report provides a comprehensive analysis of the global Advanced Drug Delivery Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Advanced Drug Delivery Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Advanced Drug Delivery Systems market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Advanced Drug Delivery Systems and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Advanced Drug Delivery Systems.
The global Advanced Drug Delivery Systems market size is projected to grow from US$ 174650 million in 2022 to US$ 213400 million in 2029; it is expected to grow at a CAGR of 2.9% from 2023 to 2029.
Various advantages of advanced drug delivery systems over the conventional delivery systems such as on site action, reduce dosing amount, increased drug efficacy, therapeutic success rate etc. support its market growth. In addition, increasing clinical research activities in the development of more advanced drug delivery systems would also be fuelling the market growth. Certain technical limitations in the development of methods, stringent regulations, high pricing for the advanced products, non-availability in the low income countries are some of the factors limiting the market growth of global advanced drug delivery systems.
This report presents a comprehensive overview, market shares, and growth opportunities of Advanced Drug Delivery Systems market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Oral Drug Delivery
Pulmonary Drug Delivery
Transdermal Drug Delivery
Parenteral Drug Delivery
Segmentation by application
Hospitals
Specialized Clinics
Clinical Research & Development Centers
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
NeXstar Pharmaceuticals
West Pharmaceutical Services
AstraZeneca
Sequus Pharmaceuticals
3M
Novartis International
Please note: The report will take approximately 2 business days to prepare and deliver.